These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32963099)

  • 21. Ca
    Khelashvili G; Plante A; Doktorova M; Weinstein H
    bioRxiv; 2021 Jan; ():. PubMed ID: 33299996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 inhibitory activity of a short peptide derived from internal fusion peptide of S2 subunit of spike glycoprotein.
    Stincarelli MA; Quagliata M; Di Santo A; Pacini L; Fernandez FR; Arvia R; Rinaldi S; Papini AM; Rovero P; Giannecchini S
    Virus Res; 2023 Sep; 334():199170. PubMed ID: 37422270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2.
    Verkhivker G
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158276
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Maurya AK; Mishra N
    J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computational Mutagenesis at the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Binding Interface: Comparison with Experimental Evidence.
    Laurini E; Marson D; Aulic S; Fermeglia A; Pricl S
    ACS Nano; 2021 Apr; 15(4):6929-6948. PubMed ID: 33733740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of SARS-CoV-2 surface therapeutic targets and drugs using molecular modeling methods for inhibition of the virus entry.
    Farhadian S; Heidari-Soureshjani E; Hashemi-Shahraki F; Hasanpour-Dehkordi A; Uversky VN; Shirani M; Shareghi B; Sadeghi M; Pirali E; Hadi-Alijanvand S
    J Mol Struct; 2022 May; 1256():132488. PubMed ID: 35125515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
    Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
    Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Homologous modeling and binding ability analysis of Spike protein after point mutation of severe acute respiratory syndrome coronavirus 2 to receptor proteins and potential antiviral drugs].
    Cao Z; Wang LT; Liu ZM
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 53(1):150-158. PubMed ID: 33550350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In silico drug repositioning against human NRP1 to block SARS-CoV-2 host entry.
    Gül Ş
    Turk J Biol; 2021; 45(4):442-458. PubMed ID: 34803446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of small molecule entry inhibitors targeting the linoleic acid binding pocket of SARS-CoV-2 spike protein.
    Prasad R; Kadam A; Padippurackal VV; Pulikuttymadom Balasubramanian A; Kumar Chandrakumaran N; Suresh Rangari K; Dnyaneshwar Khangar P; Ajith H; Natarajan K; Chandramohanadas R; Nelson-Sathi S
    J Biomol Struct Dyn; 2024 Mar; ():1-15. PubMed ID: 38520147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Membrane cholesterol regulates the oligomerization and fusogenicity of SARS-CoV fusion peptide: implications in viral entry.
    Meher G; Bhattacharjya S; Chakraborty H
    Phys Chem Chem Phys; 2023 Mar; 25(11):7815-7824. PubMed ID: 36857640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Docking and Dynamics Simulation of Several Flavonoids Predict Cyanidin as an Effective Drug Candidate against SARS-CoV-2 Spike Protein.
    Shrestha A; Marahatha R; Basnet S; Regmi BP; Katuwal S; Dahal SR; Sharma KR; Adhikari A; Chandra Basnyat R; Parajuli N
    Adv Pharmacol Pharm Sci; 2022; 2022():3742318. PubMed ID: 36407836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conformational dynamics of SARS-CoV-2 Omicron spike trimers during fusion activation at single molecule resolution.
    Dey S; Pahari P; Mukherjee S; Munro JB; Das DK
    Structure; 2024 Oct; ():. PubMed ID: 39366371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cooperative multivalent receptor binding promotes exposure of the SARS-CoV-2 fusion machinery core.
    Pak AJ; Yu A; Ke Z; Briggs JAG; Voth GA
    bioRxiv; 2021 Jun; ():. PubMed ID: 34127973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computational insights into binding mechanism of drugs as potential inhibitors against SARS-CoV-2 targets.
    Arooj M; Shehadi I; Nassab CN; Mohamed AA
    Chem Zvesti; 2022; 76(1):111-121. PubMed ID: 34483461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of peptide binding to the SARS-CoV-2 host factor neuropilin.
    Jobe A; Vijayan R
    Heliyon; 2021 Oct; 7(10):e08251. PubMed ID: 34722943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Membrane Cholesterol Modulates Oligomeric Status and Peptide-Membrane Interaction of Severe Acute Respiratory Syndrome Coronavirus Fusion Peptide.
    Meher G; Bhattacharjya S; Chakraborty H
    J Phys Chem B; 2019 Dec; 123(50):10654-10662. PubMed ID: 31743644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the
    Al-Karmalawy AA; Dahab MA; Metwaly AM; Elhady SS; Elkaeed EB; Eissa IH; Darwish KM
    Front Chem; 2021; 9():661230. PubMed ID: 34017819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural-Based Virtual Screening of FDA-Approved Drugs Repository for NSP16 Inhibitors, Essential for SARS-COV-2 Invasion Into Host Cells: Elucidation From MM/PBSA Calculation.
    Kumar S; Singh H; Prajapat M; Sarma P; Bhattacharyya A; Kaur H; Kaur G; Shekhar N; Kaushal K; Kumari K; Bansal S; Mahendiratta S; Chauhan A; Singh A; Soloman Singh R; Sharma S; Thota P; Avti P; Prakash A; Kuhad A; Medhi B
    Bioinform Biol Insights; 2023; 17():11779322231171777. PubMed ID: 37533429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Mechanistic Understanding of the Modes of Ca
    Carten JD; Khelashvili G; Bidon MK; Straus MR; Tang T; Jaimes JA; Whittaker GR; Weinstein H; Daniel S
    ACS Infect Dis; 2024 Feb; 10(2):398-411. PubMed ID: 38270149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.